Sol-gel technologies reports full year 2021 financial results and corporate developments

Ness ziona, israel, march 30, 2022 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl), a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced financial results for the full year ended december 31, 2021, and provided recent corporate updates.
SLGL Ratings Summary
SLGL Quant Ranking